Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market: By Service (Pharmaceutical Manufacturing Services, Drug Development Services and Biologics Manufacturing Services), By End User (Small & Mid-Size Pharma, Generic Pharmaceutical Companies, Big Pharma and Other End Users) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Pharmaceutical Contract Development And Manufacturing Organization Market size was valued at 92.1 billion in 2021 and is expected to reach 145.0 million by 2028, at a CAGR of 6.7% during the forecast period 2022 to 2028.  Some of the key factors fueling the market growth include increasing investments in pharmaceutical R&D, advent of CDMO model into the outsourcing model, growing subcontracting volume by big pharmaceutical companies and rising healthcare standards in developing countries,. However, increasing lead time and logistics costs, stringent regulatory requirements and changing trade policies between countries are hindering the market growth. In addition, increasing outsourcing of clinical trials to emerging markets and growing focus on specialty medicines provides huge growth opportunity for the market. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global pharmaceutical contract development and manufacturing organization market market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global pharmaceutical contract development and manufacturing organization (CDMO) products.

Recent Market Developments:

In February 2022, Recipharm acquired Portuguese CDMO GenIbet, specializes in producing biological clinical trial material and other viral vectors to expand its biologics operations with a focus on drug substance production for advanced products. In December 2021, SGS acquired Quay Pharmaceuticals Limited to provide extensive range of support and services to its clients.

Pharmaceutical CDMO Market

MARKET SUMMARY
-
6.7%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.7%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Pharmaceutical CDMO Market

  • The report gives comprehensive outlook on Pharmaceutical CDMO Market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of service, end user and region
Key Players
  • Thermo Fisher Scientific Inc
  • Vetter Pharma International
  • Lonza Group
  • Recipharm AB
  • Catalent
Pharmaceutical CDMO Market

DRIVERS AND RESTRAINTS

As the population increases and the number of regional markets entering the global landscape continues to increase, drug companies are feeling pressure to bring drugs to market more rapidly. CDMO outsourcing remains a key strategy for easing the pressures of development. In particular, API manufacturing has kept a firm position as the most outsourced area for drug manufacturers. This has led to healthy growth related with the sector, which is likely to steadily rise, especially over the short term. Pharma companies often need to access specialised manufacturing resources, facilities and capabilities to progress a drug from development through to commercial production. The outsourcing landscape is very fragmented and highly competitive, with a wide range of full service and niche contract development and manufacturing organisations (CDMOs) to choose from, as well as pure play and embedded CDMOs. The embedded CDMO is a unique option within the pharma and biopharma outsourcing space.


Asia-Pacific Got Significant Share

Pharmaceutical CDMO Market

Asia Pacific accounted for larger revenue share in global pharmaceutical contract development and manufacturing organization (CDMO) market with considerable CAGR. The growth in this region is due to growing incidences of chronic and lifestyle diseases, availability of expertise for clinical trials and increase in the outsourcing of research processes. Improving healthcare infrastructure and increasing favourable government initiatives are other factors responsible for market growth. China and India are the major contributors for the growth of the market in the region. North America held substantial market share during estimated period owing to increasing research activities by biotechnology companies and the rising demand for generics.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Global pharmaceutical contract development and manufacturing organization (CDMO) market expanding at significant CAGR over 2022 to 2028 due to increasing investments in pharmaceutical R&D
  • Based on services, pharmaceutical manufacturing services segment accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

Key

Features of the Report

Pharmaceutical CDMO Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Introduction
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Taxonomy
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market –Definitions
      • Service
      • End User
  1. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamic Factors – Impact Analysis
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Competition Landscape
  2. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Service, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Pharmaceutical Manufacturing Services
      • Pharmaceutical FDF Manufacturing Services
        • Tablet Manufacturing Services
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Capsule Manufacturing Services
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Oral Liquid Manufacturing Services
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Parenteral/Injectable Manufacturing Services
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Other Formulations
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Drug Development Services
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Biologics Manufacturing Services
          • Biologics FDF Manufacturing Services
            • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Biologics API Manufacturing Services
            • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
  1. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025
    • Small & Mid-Size Pharma
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Generic Pharmaceutical Companies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Big Pharma
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other End Users
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service, End User and Region, 2019 – 2025
  2. North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Service Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • US
        • Canada
      • North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service, End User and Country, 2019 – 2025
      • North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics – Trends
  1. Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Service Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service, End User and Country, 2019 – 2025
      • Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics – Trends
  1. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Service Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service, End User and Country, 2019 – 2025
      • Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics – Trends
  1. Latin America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Service Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • Latin America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service, End User and Country, 2019 – 2025
      • Latin America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics – Trends
  1. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Service Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service, End User and Country, 2019 – 2025
      • MEA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, End User & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Thermo Fisher Scientific Inc. (US)
      • Catalent (US)
      • Lonza Group (Switzerland)
      • Recipharm AB (Sweden)
      • Vetter Pharma International GMBH (Germany)
      • FAMAR Health Care Services (Greece)
      • AbbVie (US)
      • Aenova Group (Germany)
      • Consort Medical (UK)
      • Almac Group (UK)
      • Siegfried Holding AG (Switzerland)
      • Boehringer Ingelheim International GmbH (Germany)
      • Evonik Industries AG (Germany)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Thermo Fisher Scientific Inc. (US)
  • Catalent (US)
  • Lonza Group (Switzerland)
  • Recipharm AB (Sweden)
  • Vetter Pharma International GMBH (Germany)
  • FAMAR Health Care Services (Greece)
  • AbbVie (US)
  • Aenova Group (Germany)
  • Consort Medical (UK)
  • Almac Group (UK)
  • Siegfried Holding AG (Switzerland)
  • Boehringer Ingelheim International GmbH (Germany)
  • Evonik Industries AG (Germany)

Report

List of Tables and Figures

List of Tables:

Table 01: Global Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2014-2025

Table 02: Global Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 03: Global Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Application, 2014-2025

Table 04: Global Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 05: Global Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Region, 2014-2025

Table 06: North America Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 07: North America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2014-2025

Table 08: North America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 09: North America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Application, 2014-2025

Table 10: North America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 11: Europe Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 12: Europe Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2014-2025

Table 13: Europe Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 14: Europe Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Application, 2014-2025

Table 15: Europe Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 16: Asia Pacific Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 17: Asia Pacific Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2014-2025

Table 18: Asia Pacific Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 19: Asia Pacific Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Application, 2014-2025

Table 20: Asia Pacific Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 21: Latin America Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 22: Latin America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2014-2025

Table 23: Latin America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 24: Latin America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Application, 2014-2025

Table 25: Latin America Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 26: Middle East & Africa Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 27: Middle East & Africa Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2014-2025

Table 28: Middle East & Africa Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 29: Middle East & Africa Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By Application, 2014-2025

Table 30: Middle East & Africa Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

List of Figures:

Figure 01: Global Semen Analysis Market Revenue Share (%), by Product Type (2018)

Figure 02: Global Semen Analysis Market Revenue Share ($ Mn), by Sample Source (2018, 2025)

Figure 03: Global Semen Analysis Market Revenue Share ($ Mn), by Application (2018)

Figure 04: Global Semen Analysis Market Revenue Share (%), by End User (2018)

Figure 05: Global Semen Analysis Market Revenue Share (%) by Region (2018)

Figure 06: Global Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn), and Y-o-Y Growth (%), 2014-2025

Figure 07: Global Semen Analysis Market– Market Opportunity (US$ Mn) 2014, 2018, & 2025

Figure 08: Global Semen Analysis Market Share (%), By Product Type, 2019 & 2025

Figure 09: Global Semen Analysis Market Y-o-Y Growth (%), by Product Type, 2018-2025

Figure 10: Instruments – Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014 – 2025

Figure 11: Reagents and Kits – Historical, Forecast Market Sizes (US$ Mn) Market Opportunity (US$ Mn), 2014 – 2025

Figure 12: Software – Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014 – 2025

Figure 13: Global Semen Analysis Market Share (%), By Sample Source, 2019 & 2025

Figure 14: Global Semen Analysis Market Y-o-Y Growth (%), by Sample Source, 2018-2025

Figure 15: Human- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 16: Veterinary – Historical, Forecast Market Sizes (US$ Mn) Market Opportunity (US$ Mn), 2014-2025

Figure 17: Global Semen Analysis Market Share (%), By Application, 2019 & 2025

Figure 18: Global Semen Analysis Market Y-o-Y Growth (%), by Application, 2018-2025

Figure 19: Semen Count – Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 20: Diagnosis – Historical, Forecast Market Sizes (US$ Mn) Market Opportunity (US$ Mn), 2014-2025

Figure 21: Others – Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 22: Global Semen Analysis Market Share (%), By End User, 2019 & 2025

Figure 23: Global Semen Analysis Market Y-o-Y Growth (%), by End User, 2018-2025

Figure 24: Hospitals – Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 25: Diagnostics Centers – Historical, Forecast Market Sizes (US$ Mn) Market Opportunity (US$ Mn), 2014-2025

Figure 26: Fertility Centers – Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 27: Fertility Centers – Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 28: Global Semen Analysis Market Share (%), By Region, 2019 & 2025

Figure 29: Global Semen Analysis Market Y-o-Y Growth (%), by Region, 2018-2025

Figure 30: North America Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 31: Europe Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 32: Asia Pacific Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 33: Latin America Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 34: Middle East & Africa Semen Analysis Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 35: Global Semen Analysis Market – Opportunity Analysis, By Product Type 2018 – 2025

Figure 36: Global Semen Analysis Market – Opportunity Analysis, By Sample Source, 2018 – 2025

Figure 37: Global Semen Analysis Market – Opportunity Analysis, By Application, 2018 – 2025

Figure 38: Global Semen Analysis Market – Opportunity Analysis, By End User 2018 – 2025

Figure 39: Global Semen Analysis Market – Opportunity Analysis, By Sample Source, 2018 – 2025

Figure 40: North America Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 41: North America Semen Analysis Market– Market Opportunity (US$ Mn), 2014, 2018, & 2025

Figure 42: North America Semen Analysis Market Share Analysis (%), by Product Type, 2018

Figure 43: North America Semen Analysis Market Share Analysis (%), by Sample Source, 2018

Figure 44: North America Semen Analysis Market Share Analysis (%), by Application, 2018

Figure 45: North America Semen Analysis Market Share Analysis (%), by End User, 2018

Figure 46: North America Semen Analysis Market Share Analysis (%), by Country, 2018

Figure 47: North America Semen Analysis Market – Opportunity Analysis, By Product Type 2018 – 2025

Figure 48: North America Semen Analysis Market – Opportunity Analysis, By Sample Source, 2018 – 2025

Figure 49: North America Semen Analysis Market – Opportunity Analysis, By Application, 2018 – 2025

Figure 50: North America Semen Analysis Market – Opportunity Analysis, By End User 2018 – 2025

Figure 51: North America Semen Analysis Market – Opportunity Analysis, By Region, 2018 – 2025

Figure 52: Europe Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 53: Europe Semen Analysis Market– Market Opportunity (US$ Mn), 2014, 2018, & 2025

Figure 54: Europe Semen Analysis Market Share Analysis (%), by Product Type, 2018

Figure 55: Europe Semen Analysis Market Share Analysis (%), by Sample Source, 2018

Figure 56: Europe Semen Analysis Market Share Analysis (%), by Application, 2018

Figure 57: Europe Semen Analysis Market Share Analysis (%), by End User, 2018

Figure 58: Europe Semen Analysis Market Share Analysis (%), by Country, 2018

Figure 59: Europe Semen Analysis Market – Opportunity Analysis, By Product Type 2018 – 2025

Figure 60: Europe Semen Analysis Market – Opportunity Analysis, By Sample Source, 2018 – 2025

Figure 61: Europe Semen Analysis Market – Opportunity Analysis, By Application, 2018 – 2025

Figure 62: Europe Semen Analysis Market – Opportunity Analysis, By End User 2018 – 2025

Figure 63: Europe Semen Analysis Market – Opportunity Analysis, By Region, 2018 – 2025

Figure 64: Asia Pacific Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 65: Asia Pacific Semen Analysis Market– Market Opportunity (US$ Mn), 2014, 2018, & 2025

Figure 66: Asia Pacific Semen Analysis Market Share Analysis (%), by Product Type, 2018

Figure 67: Asia Pacific Semen Analysis Market Share Analysis (%), by Sample Source, 2018

Figure 68: Asia Pacific Semen Analysis Market Share Analysis (%), by Application, 2018

Figure 69: Asia Pacific Semen Analysis Market Share Analysis (%), by End User, 2018

Figure 70: Asia Pacific Semen Analysis Market Share Analysis (%), by Country, 2018

Figure 71: Asia Pacific Semen Analysis Market – Opportunity Analysis, By Product Type 2018 – 2025

Figure 72: Asia Pacific Semen Analysis Market – Opportunity Analysis, By Sample Source, 2018 – 2025

Figure 73: Asia Pacific Semen Analysis Market – Opportunity Analysis, By Application, 2018 – 2025

Figure 74: Asia Pacific Semen Analysis Market – Opportunity Analysis, By End User 2018 – 2025

Figure 75: Asia Pacific Semen Analysis Market – Opportunity Analysis, By Region, 2018 – 2025

Figure 76: Latin America Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 77: Latin America Semen Analysis Market– Market Opportunity (US$ Mn), 2014, 2018, & 2025

Figure 78: Latin America Semen Analysis Market Share Analysis (%), by Product Type, 2018

Figure 79: Latin America Semen Analysis Market Share Analysis (%), by Sample Source, 2018

Figure 80: Latin America Semen Analysis Market Share Analysis (%), by Application, 2018

Figure 81: Latin America Semen Analysis Market Share Analysis (%), by End User, 2018

Figure 82: Latin America Semen Analysis Market Share Analysis (%), by Country, 2018

Figure 83: Latin America Semen Analysis Market – Opportunity Analysis, By Product Type 2018 – 2025

Figure 84: Latin America Semen Analysis Market – Opportunity Analysis, By Sample Source, 2018 – 2025

Figure 85: Latin America Semen Analysis Market – Opportunity Analysis, By Application, 2018 – 2025

“Figure 86: Latin America Semen Analysis Market – Opportunity Analysis, By End User 2018 – 2025

Figure 87: Latin America Semen Analysis Market – Opportunity Analysis, By Region, 2018 – 2025

Figure 88: Middle East & Africa Semen Analysis Market- Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 89: Middle East & Africa Semen Analysis Market– Market Opportunity (US$ Mn), 2014, 2018, & 2025

Figure 90: Middle East & Africa Semen Analysis Market Share Analysis (%), by Product Type, 2018

Figure 91: Middle East & Africa Semen Analysis Market Share Analysis (%), by Sample Source, 2018

Figure 92: Middle East & Africa Semen Analysis Market Share Analysis (%), by Application, 2018

Figure 93: Middle East & Africa Semen Analysis Market Share Analysis (%), by End User, 2018

Figure 94: Middle East & Africa Semen Analysis Market Share Analysis (%), by Country, 2018

Figure 95: Middle East & Africa Semen Analysis Market – Opportunity Analysis, By Product Type 2018 – 2025

Figure 96: Middle East & Africa Semen Analysis Market – Opportunity Analysis, By Sample Source, 2018 – 2025

Figure 97: Middle East & Africa Semen Analysis Market – Opportunity Analysis, By Application, 2018 – 2025

Figure 98: Middle East & Africa Semen Analysis Market – Opportunity Analysis, By End User 2018 – 2025

Figure 99: Middle East & Africa Semen Analysis Market – Opportunity Analysis, By Region, 2018 – 2025

Description

Pharmaceutical Contract Development And Manufacturing Organization Market size was valued at 92.1 billion in 2021 and is expected to reach 145.0 million by 2028, at a CAGR of 6.7% during the forecast period 2022 to 2028.  Some of the key factors fueling the market growth include increasing investments in pharmaceutical R&D, advent of CDMO model into the outsourcing model, growing subcontracting volume by big pharmaceutical companies and rising healthcare standards in developing countries,. However, increasing lead time and logistics costs, stringent regulatory requirements and changing trade policies between countries are hindering the market growth. In addition, increasing outsourcing of clinical trials to emerging markets and growing focus on specialty medicines provides huge growth opportunity for the market. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global pharmaceutical contract development and manufacturing organization market market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global pharmaceutical contract development and manufacturing organization (CDMO) products.

Recent Market Developments:

In February 2022, Recipharm acquired Portuguese CDMO GenIbet, specializes in producing biological clinical trial material and other viral vectors to expand its biologics operations with a focus on drug substance production for advanced products. In December 2021, SGS acquired Quay Pharmaceuticals Limited to provide extensive range of support and services to its clients.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX